SARS-CoV-2 B.1.214.1, B.1.214.2 and B.1.620 are predominant lineages between December 2020 and July 2021 in the Republic of Congo-Reference-Cited by-同舟云学术

SARS-CoV-2 B.1.214.1, B.1.214.2 and B.1.620 are predominant lineages between December 2020 and July 2021 in the Republic of Congo

Published:2022-06 Issue: Volume:3 Page:106-113
ISSN:2772-7076
Container-title:IJID Regions
language:en
Short-container-title:IJID Regions

Author:

Mfoutou Mapanguy Claujens Chastel,Batchi-Bouyou Armel Landry^ORCID,Djontu Jean Claude,Pallerla Srinivas Reddy^ORCID,Ngoma Chamy Helga,Linh Le Thi Kieu,Rachakonda Sivaramakrishna,Casadei Nicolas^ORCID,Angelov Angel,Sonnabend Michael,Vouvoungui Jeannhey Christevy^ORCID,Ampa Raoul,Nguimbi Etienne,Peter Silke,Kremsner Peter G,Montaldo Chiara^ORCID,Velavan Thirumalaisamy P.,Ntoumi Francine

Publisher

Elsevier BV

Reference38 articles.

1. Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020;Bal;Euro Surveill,2021

2. High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo;Batchi-Bouyou;Int J Infect Dis,2021

3. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study;Challen;BMJ,2021

4. 'Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7′;Davies;Nature,2021

5. Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions;Dudas;Nat Commun,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutralizing antibody responses assessment after vaccination in people living with HIV using a surrogate neutralization assay;BMC Immunology;2024-07-10

2. Emergence of the B.1.214.2 SARS-CoV-2 lineage with an Omicron-like spike insertion and a unique upper airway immune signature;2024-05-03

3. COVID-19 Genomic Surveillance in Bangui (Central African Republic) Reveals a Landscape of Circulating Variants Linked to Validated Antiviral Targets of SARS-CoV-2 Proteome;Viruses;2023-11-24